631 related articles for article (PubMed ID: 32624559)
41. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis.
Machingaidze S; Wiysonge CS; Gonzalez-Angulo Y; Hatherill M; Moyo S; Hanekom W; Mahomed H
Pediatr Infect Dis J; 2011 Aug; 30(8):694-700. PubMed ID: 21427627
[TBL] [Abstract][Full Text] [Related]
42. Prevalence of latent tuberculosis infection in Sudan: a case-control study comparing interferon-γ release assay and tuberculin skin test.
Shakak AO; Khalil EA; Musa AM; Salih KA; Bashir AE; Ahmed AH; Idris FE; Elhassan AM;
BMC Public Health; 2013 Dec; 13():1128. PubMed ID: 24313987
[TBL] [Abstract][Full Text] [Related]
43. Interferon-gamma release assay test characteristics depend upon the prevalence of active tuberculosis.
Davidow AL
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1411-5. PubMed ID: 19861015
[TBL] [Abstract][Full Text] [Related]
44. Mycobacteria-Specific Mono- and Polyfunctional CD4+ T Cell Profiles in Children With Latent and Active Tuberculosis: A Prospective Proof-of-Concept Study.
Tebruegge M; Ritz N; Donath S; Dutta B; Forbes B; Clifford V; Zufferey C; De Rose R; Robins-Browne RM; Hanekom W; Graham SM; Connell T; Curtis N
Front Immunol; 2019; 10():431. PubMed ID: 31024518
[No Abstract] [Full Text] [Related]
45. Latent Mycobacterium tuberculosis Infection and Interferon-Gamma Release Assays.
Pai M; Behr M
Microbiol Spectr; 2016 Oct; 4(5):. PubMed ID: 27763261
[TBL] [Abstract][Full Text] [Related]
46. Tuberculin skin test versus interferon-gamma release assays for the diagnosis of tuberculosis infection.
De Keyser E; De Keyser F; De Baets F
Acta Clin Belg; 2014 Oct; 69(5):358-66. PubMed ID: 25018132
[TBL] [Abstract][Full Text] [Related]
47. Interferon-γ release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis.
Zhou G; Luo Q; Luo S; Teng Z; Ji Z; Yang J; Wang F; Wen S; Ding Z; Li L; Chen T; Abi ME; Jian M; Luo L; Liu A; Bao F
Lancet Infect Dis; 2020 Dec; 20(12):1457-1469. PubMed ID: 32673595
[TBL] [Abstract][Full Text] [Related]
48. Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection.
Gupta D; Kumar S; Aggarwal AN; Verma I; Agarwal R
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):95-101. PubMed ID: 22117500
[TBL] [Abstract][Full Text] [Related]
49. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients.
Seyhan EC; Sökücü S; Altin S; Günlüoğlu G; Trablus S; Yilmaz D; Koksalan OK; Issever H
Transpl Infect Dis; 2010 Apr; 12(2):98-105. PubMed ID: 19903322
[TBL] [Abstract][Full Text] [Related]
50. Can ELISpot replace the tuberculin skin test for latent tuberculosis?
Greveson K
Br J Nurs; 2009 Nov 12-25; 18(20):1248-54. PubMed ID: 20081663
[TBL] [Abstract][Full Text] [Related]
51. How to use: interferon γ release assays for tuberculosis.
Pollock L; Basu Roy R; Kampmann B
Arch Dis Child Educ Pract Ed; 2013 Jun; 98(3):99-105. PubMed ID: 23580543
[TBL] [Abstract][Full Text] [Related]
52. A Mycobacterium tuberculosis Dormancy Antigen Differentiates Latently Infected Bacillus Calmette-Guérin-vaccinated Individuals.
Peña D; Rovetta AI; Hernández Del Pino RE; Amiano NO; Pasquinelli V; Pellegrini JM; Tateosian NL; Rolandelli A; Gutierrez M; Musella RM; Palmero DJ; Gherardi MM; Iovanna J; Chuluyan HE; García VE
EBioMedicine; 2015 Aug; 2(8):884-90. PubMed ID: 26425695
[TBL] [Abstract][Full Text] [Related]
53. Evaluating Latent Tuberculosis Infection Test Performance Using Latent Class Analysis in a TB and HIV Endemic Setting.
Adams S; Ehrlich R; Baatjies R; Dendukuri N; Wang Z; Dheda K
Int J Environ Res Public Health; 2019 Aug; 16(16):. PubMed ID: 31416206
[TBL] [Abstract][Full Text] [Related]
54. Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Kahwati LC; Feltner C; Halpern M; Woodell CL; Boland E; Amick HR; Weber RP; Jonas DE
JAMA; 2016 Sep; 316(9):970-83. PubMed ID: 27599332
[TBL] [Abstract][Full Text] [Related]
55. Management of latent tuberculosis infection in China: Exploring solutions suitable for high-burden countries.
Cui X; Gao L; Cao B
Int J Infect Dis; 2020 Mar; 92S():S37-S40. PubMed ID: 32114201
[TBL] [Abstract][Full Text] [Related]
56. Diagnosing latent tuberculosis infection in haemodialysis patients: T-cell based assay (T-SPOT.TB) or tuberculin skin test?
Soysal A; Toprak D; Koc M; Arikan H; Akoglu E; Bakir M
Nephrol Dial Transplant; 2012 Apr; 27(4):1645-50. PubMed ID: 21931124
[TBL] [Abstract][Full Text] [Related]
57. Is the T-cell-based interferon-gamma releasing assay feasible for diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country?
Dilektasli AG; Erdem E; Durukan E; Eyüboğlu FÖ
Jpn J Infect Dis; 2010 Nov; 63(6):433-6. PubMed ID: 21099095
[TBL] [Abstract][Full Text] [Related]
58. Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy.
Sellam J; Hamdi H; Roy C; Baron G; Lemann M; Puéchal X; Breban M; Berenbaum F; Humbert M; Weldingh K; Salmon D; Ravaud P; Emilie D; Mariette X;
Ann Rheum Dis; 2007 Dec; 66(12):1610-5. PubMed ID: 17456528
[TBL] [Abstract][Full Text] [Related]
59. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
So H; Yuen CS; Yip RM
Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
